Nasdaq

Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Monthly Prescribing Reference

Dexcom Stelo Biosensor Cleared as First OTC Continuous Glucose Monitor

Credit: Dexcom. The Dexcom Stelo Glucose Biosensor System is an integral CGM intended for individuals 18 years of age and older with or without diabetes who are not on insulin. The Food and Drug ...
Business Wire

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
FierceBiotech

Dexcom's Stelo, its first over-the-counter glucose monitor, hits the market

After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now available ...
Monthly Prescribing Reference

Stelo OTC Wearable Glucose Biosensor Now Available

Credit: Dexcom. Stelo is an integrated CGM that continuously measures, records, analyzes, and displays glucose values in individuals 18 years of age and older who are not on insulin. Dexcom’s Stelo ...
VentureBeat

Dexcom Stelo is the 1st glucose monitor for those with prediabetes condition

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
San Diego Union-Tribune

Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs

San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
Benzinga.com

FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription

Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is ...
MD&M East

Oura & Stelo Marry to Deliver AI-driven Approach to Metabolic Health

Oura announced on May 6 that its smart ring has added two new metabolic health features, Meals and Glucose. That’s thanks to a union of the ring’s artificial intelligence with glucose data from Dexcom ...
WRIC

Stelo Files Complaint Against Dexcom, Inc. for Trademark Infringement, Negligence, Unfair Competition

SAN FRANCISCO, June 23, 2025 /PRNewswire/ -- Stelo, an enterprise software company, has filed suit in Federal District Court for the Central District of California against San Diego-based Dexcom, Inc.
Nasdaq

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

Stelo will be the first glucose biosensor in the US cleared for use without a prescription Indicated for use for people 18 years and older who are not using insulin therapy A small, wearable sensor ...